Imago Stock Analysis

IMGO -  USA Stock  

USD 17.71  0.13  0.73%

The big decline in price over the last few months for Imago Biosciencesmay raise some interest from institutional investors. The stock closed today at a share price of 17.71 on 550,800 in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Imago Biosciences or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.49. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Imago Biosciences partners.
Please see Risk vs Return Analysis.

Imago Stock Analysis 

 
Refresh
The Imago Biosciences stock analysis report makes it easy to digest most publicly released information about Imago Biosciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Imago Stock analysis module also helps to analyze the Imago Biosciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Imago Stock Analysis Notes

About 72.0% of the company shares are owned by institutional investors. The book value of Imago Biosciences was currently reported as 6.83. The company recorded a loss per share of 4.41. Imago Biosciences had not issued any dividends in recent years. Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1, an enzyme that used in the production of blood cells in the bone marrow. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Imago Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people. To learn more about Imago Biosciences call the company at 415-529-5055 or check out https://www.imagobio.com.

Imago Biosciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Imago Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Imago Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Imago Biosciences generated a negative expected return over the last 90 days
Imago Biosciences has high historical volatility and very poor performance
Imago Biosciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (33.13 M).
Imago Biosciences currently holds about 230.35 M in cash with (31.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.87.
Imago Biosciences has a very weak financial position based on the latest SEC disclosures
Roughly 72.0% of the company shares are owned by institutional investors
Latest headline from www.nasdaq.com: Were Not Very Worried About COMPASS Pathways Cash Burn Rate - Nasdaq

Imago Biosciences Upcoming and Recent Events

Earnings reports are used by Imago Biosciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Imago Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report9th of February 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End9th of February 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Imago Largest EPS Surprises

Earnings surprises can significantly impact Imago Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-11-10
2021-09-30-0.3633-0.44-0.076721 
2021-08-19
2021-06-30-0.3375-8.13-7.79252308 
View All Earnings Estimates

Imago Biosciences SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Imago Biosciences prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Imago Biosciences investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Imago Biosciences specific information freely available to individual and institutional investors to make a timely investment decision.
12th of January 2022
Other Events
View
13th of December 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
19th of November 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
10th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
30th of September 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
19th of August 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
30th of July 2021
Unclassified Corporate Event. Unclassified Corporate Event
View
27th of July 2021
Unclassified Corporate Event
View

Imago Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Imago Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Imago Biosciences backward and forwards among themselves. Imago Biosciences' institutional investor refers to the entity that pools money to purchase Imago Biosciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackstone IncCommon Shares3.4 M67.6 M
Omega Fund Management LlcCommon SharesM60.5 M
Frazier Management LlcCommon SharesM59.5 M
Farallon Capital Management LlcCommon Shares2.7 M53.5 M
Price T Rowe Associates IncCommon Shares2.2 M42.7 M
Fmr LlcCommon Shares2.1 M41.2 M
Citadel Advisors LlcCommon SharesM40.1 M
Note, although Imago Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Imago Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 588.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Imago Biosciences's market, we take the total number of its shares issued and multiply it by Imago Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Imago Profitablity

Imago Biosciences' profitability indicators refer to fundamental financial ratios that showcase Imago Biosciences' ability to generate income relative to its revenue or operating costs. If, let's say, Imago Biosciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Imago Biosciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Imago Biosciences' profitability requires more research than a typical breakdown of Imago Biosciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.30) (0.32) 
Return on Average Equity 0.27  0.27 
Return on Invested Capital(0.43) (0.46) 

Management Efficiency

The value of Return on Average Assets is estimated to slide to -0.32. The value of Return on Invested Capital is expected to slide to -0.46. Assets Non Current is expected to rise to about 26.2 M this year, although the value of Total Assets will most likely fall to about 91 M. Imago Biosciences management efficiency ratios could be used to measure how well imago biosciences manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2022
Book Value per Share(60.71) (65.51) 
Tangible Assets Book Value per Share 111.58  89.23 
Tangible Asset Value113.8 M91 M

Technical Drivers

As of the 23rd of January, Imago Biosciences retains the risk adjusted performance of (0.031774), and Market Risk Adjusted Performance of (0.36). Imago Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Imago Biosciences, which can be compared to its competitors. Please check out Imago Biosciences standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Imago Biosciences is priced fairly, providing market reflects its last-minute price of 17.71 per share. Given that Imago Biosciences has jensen alpha of (0.27), we strongly advise you to confirm Imago Biosciences's regular market performance to make sure the company can sustain itself at a future point.

Imago Biosciences Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of Imago Biosciences more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Imago Biosciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Imago Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Imago Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Imago Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Imago Biosciences Predictive Daily Indicators

Imago Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Imago Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Imago Biosciences Forecast Models

Imago Biosciences time-series forecasting models is one of many Imago Biosciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Imago Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Imago Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Imago Biosciences stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Imago shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Imago Biosciences. By using and applying Imago Stock analysis, traders can create a robust methodology for identifying Imago entry and exit points for their positions.
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1, an enzyme that used in the production of blood cells in the bone marrow. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Imago Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.

Current Imago Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Imago analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Imago analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
35.33Strong Buy3Odds
Imago Biosciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Imago analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Imago stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Imago Biosciences, talking to its executives and customers, or listening to Imago conference calls.
Imago Analyst Advice Details

Imago Stock Analysis Indicators

Imago Biosciences stock analysis indicators help investors evaluate how Imago Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Imago Biosciences shares will generate the highest return on investment. By understating and applying Imago Biosciences stock analysis, traders can identify Imago Biosciences position entry and exit signals to maximize returns.
Shares Percent Shares Out4.64%
Quick Ratio25.85
Fifty Two Week Low14.61
Short Percent Of Float5.86%
Forward Price Earnings-9.69
Float Shares16.21M
Fifty Two Week High35.68
Shares Short Prior Month959.58k
Average Daily Volume Last 10 Day285.92k
Average Daily Volume In Three Month189.44k
Fifty Day Average21.91
Two Hundred Day Average22.26
Please see Risk vs Return Analysis. Note that the Imago Biosciences information on this page should be used as a complementary analysis to other Imago Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Imago Stock analysis

When running Imago Biosciences price analysis, check to measure Imago Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imago Biosciences is operating at the current time. Most of Imago Biosciences' value examination focuses on studying past and present price action to predict the probability of Imago Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Imago Biosciences' price. Additionally, you may evaluate how the addition of Imago Biosciences to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Is Imago Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Imago Biosciences. If investors know Imago will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Imago Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Imago Biosciences is measured differently than its book value, which is the value of Imago that is recorded on the company's balance sheet. Investors also form their own opinion of Imago Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Imago Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Imago Biosciences' market value can be influenced by many factors that don't directly affect Imago Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Imago Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Imago Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Imago Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.